3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pleural Effusion, Malignant
4
Breast Neoplasms
4
Immunoglobulin Light-chain Amyloidosis
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Exanthema
2
Amyloidosis
2
Waldenstrom Macroglobulinemia
1
Urologic Neoplasms
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Tissue Adhesions
1
Skin Toxicity
1
Sezary Syndrome
1
Ras-wildtype Colorectal Cancer
1
Polyps
1
Polycystic Ovary Syndrome
1
Pain
1
Ovarian Neoplasms
1
Neurofibromatosis 2
1
Neoplasms, Second Primary
1
Neoplasms
1
Myoma
1
Menstruation Disturbances
1
Melanoma
1
Interventions
Metformin
149
Clomiphene
51
Letrozole
39
Inositol
35
Folic Acid
18
Exercise
17
Progesterone
15
Ethinyl Estradiol
13
Chorionic Gonadotropin
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Estradiol
12
Contraceptives, Oral
11
cetrorelix
10
Pioglitazone
10
High-Intensity Interval Training
10
Tablets
9
Spironolactone
9
Cholecalciferol
9
Triptorelin Pamoate
8
Diet
8
Vitamin D
7
Thioctic Acid
7
Menotropins
7
Liraglutide
7
Acupuncture Therapy
7
drospirenone
6
Ovidrel
6
Gonadotropins
6
Flutamide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Polycystic Ovary Syndrome
×
Doxycycline
×
Clear all
NCT01788215
2016-01-13
MI-PCOS
University of Rochester
Phase 3
Completed
10 enrolled
14 charts